Skip to content

Maternal Role in Oral Feed Establishment in Preterm Neonates

Maternal Role in Sensory-motor Stimulation for Oral Feed Establishment in Preterm Neonates: MSMS Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05484726
Enrollment
130
Registered
2022-08-02
Start date
2022-03-01
Completion date
2023-09-06
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Maternal Care Patterns, Preterm Birth, Swallowing Disorder, Tube Feeding

Keywords

Prematurity, sensory-motor stimulation, oral feed establishment, feeding intervention

Brief summary

Hypothesis Preterm babies who receive sensory motor stimulation from their mothers as compared to trained nurses will 1. Start taking oral feed at the same time as compared to control group 2. Take the same amount of milk at the commencement of oral feeding 3. Take milk with equal efficiency 4. Not face more adverse effects

Detailed description

Aim To determine the maternal role in sensory-motor stimulation for oral feed establishment in preterm neonates Objective 1. Determine the effect of sensory-motor stimulation offered by the mother on the onset of oral feeding 2. Efficiency of mother-mediated stimulation techniques on oral feeding as compared to trained nurses 3. Study maternal role in the establishment of oral feed Hypothesis Preterm babies who receive sensory motor stimulation from their mothers as compared to trained nurses will 1\. Start taking oral feed at the same time frame as compared to the control group 2. Take the very same amount of milk at the commencement of oral feeding 3. Take milk with equal efficiency 4. There is no extra burden of adverse effects Data Collection All on going and related trials for this intervention shall be registered in the ClinicalTrials.gov. Study shall be conducted after ethical approval from IRB. All participants shall be enrolled after written informed consent from mothers after approval from attending neonatologist (annexure 2). All relevant maternal and neonatal data shall be collected on a specially designed proforma (annexure 3) with following details 1. Part 1: Maternal demographic and clinical data (age, parity, educational qualification, residence, previous preterm baby, job status, diabetes, hypertensive disorders, chronic ailment, multifetal gestation 2. Part 2: Neonatal demographic data (gender, gestation age, birth weight, growth centiles, diagnosis, APGAR score, noninvasive (NIV) and invasive ventilation with duration, caffeine, days taken for establishment of gavage feeding, age, and weight at commencement of intervention, any other complication during study) 3. Part 3: Neonatal feeding physiological measurements (SpO2, respiratory rate, heart rate before and after feeding, daily weight gain, type of milk offered) 4. Part 4: Oral feeding skill (OFS) assessment adapted from the model presented by Lau and Smith (p). All parameters shall be recorded twice a day for D1, D2, and D3 separately. It includes * Total volume prescribed (ml) * Total volume has taken during feeding (ml) * Volume has taken during the first 5 min of feeding (ml) * Duration of oral feeding (min) * Overall transfer (OT %) volume taken/total volume prescribed * Proficiency(PRO%) volume taken during the first 5 min/total volume prescribed * Rate of transfer (RT) ml/min * SSB (Suck Swallow Breaths) coordination * Adverse events (cough, fatigue) * According to this oral feeding ability can be classified into four levels depending upon the level of maturity in ascending order as follows: * Level 1: PRO \< 30% and RT \< 1.5 ml/min * Level 2: PRO \< 30% and RT ≥ 1.5 ml/min * Level 3: PRO ≥ 30% and RT \< 1.5 ml/min * Level 4: PRO ≥ 30% and RT ≥ 1.5 ml/min

Interventions

OTHERperioral sensory motor stimulation

Step 1 - 6 over 5 minutes 1 With the help of the index finger, on the external surface of the cheek, make a circle starting from the angle of the mouth towards the ear then back 7x each cheek 2 While holding both sides of the cheek with help of the thumb and index finger repeat step 1 7x each cheek 3 Move index finger from one corner to opposite one over both lips separately 7x each lip 4 Gentle massage and compress the gums from center to back of mouth 7x each half of the gum 5 Move the finger from front to back on the hard palate while applying gentle pressure 7x 6 Displace the center of the tongue with gentle pressure 7x 7 Offer pacifier at the end 2 minutes Note: 7x means 7 times

Sponsors

Fatima Memorial Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Caregiver)

Masking description

The mothers, medical staff involved in general care, nursing staff involved in the intervention, and doctors conducting the assessment of oral feeding skills (OFS) were all blinded to allocation. The nursing staff was informed at the time of intervention that participating infants would receive either sensory motor stimulation or sham oral stimulation depending on group allocation.

Intervention model description

1. Maternal involvement in perioral sensory-motor stimulation be in three stages 1. Observer status 2. Performing under supervision 3. Independent 2. Intervention period: 5 days as 1. Training phase (T): T1 and T2 (for mothers by the nurse) 2. Direct feeding phase (D): F1, 2, and 3 (oral feed shall be offered to neonate) 3. Stimulation for 7 minutes and 15 minutes before feeding twice a day at 1100 and 1700 hrs. 4. Two groups 1. Intervention group (GI): by mothers 2. Control group (G II): by staff nurses

Eligibility

Sex/Gender
ALL
Age
30 Weeks to 34 Weeks
Healthy volunteers
Yes

Inclusion criteria

* All preterm of gestation age 28 to 34weeks * Haemodynamically stable * Established full Gavage feed * No respiratory distress * No need for respiratory support except LFNC * Do not receive any kind of analgesics

Exclusion criteria

* Syndromic babies /genetic disorders * Haemodynamically unstable babies including IVH (grade III & IV), hemodynamically significant PDA on treatment, NEC(stage III) * Major malformations * Cleft lip and palate * Anemia requiring blood transfusion

Design outcomes

Primary

MeasureTime frameDescription
Transition Time to Full Oral FeedingExpected time of oral feed establishmentTime interval between commencement of perioral sensory stimulation on D1 to establishment of full oral feed in both groups. It was done daily till 14th day of perioral sensory motor stimulation. Transition time to full oral feeding was the day at which baby was able to take oral feed of volume of 120-140ml/kg/day.
Improvement (Change) in Efficiency in Oral Feed EstablishmentFor record purpose in this study results, efficacy level was noted as L4 on the following days D1, D2, D3, D5, D7 and D14According to this efficiency in oral feed establishment in terms of amount and time is determined for the intervention group vs the control group. It can be classified into four levels depending upon the level of maturity in ascending order as follows: * Level 1: PRO \< 30% and RT \< 1.5 ml/min * Level 2: PRO \< 30% and RT ≥ 1.5 ml/min * Level 3: PRO ≥ 30% and RT \< 1.5 ml/min * Level 4: PRO ≥ 30% and RT ≥ 1.5 ml/min For all neonates, efficacy was measured at 11.00 am and 5.00 pm following sensory motor stimulation for both groups till achievement of full oral feed.
•Adverse Outcome MonitoringAdverse events were noted on D1, D2,D3,D5,D7 and D14monitor for any adverse events like cough, breath holding, chocking, aspiration, tachycardia, and or bradycardia with 1. stimulation 2. feed Adverse outcome monitoring as non-life threatening adverse events including cough, tachycardia HR 180-200/min, bradycardia HR120 - 100/min, , tachypnea RR 60 - 70/min while maintaining SpO2 of \>90% at room air
•Adverse Events MonitoringAdverse events were noted on D1, D2,D3,D5,D7 and D14monitor for any adverse events like cough, breath holding, chocking, aspiration, tachycardia, and or bradycardia with 1. stimulation 2. feed Adverse outcome monitoring as non-life threatening adverse events including cough, tachycardia HR 180-200/min, bradycardia HR120 - 100/min, , tachypnea RR 60 - 70/min while maintaining SpO2 of \>90% at room air

Secondary

MeasureTime frameDescription
• Proficiency(PRO Percent) Volume Taken During the First 5 Min/Total Volume PrescribedPRO % was measured on D1, D2, D3, D5, D7 and D14how much amount of milk is taken during first 5 minutes while administering oral feeding
• Total Volume Taken During Each FeedingIt was noted on D1, D2, D3, D5, D7 and D14It is the measure of how much feed has been taken orally out of total feed prescribed for each feeding
• Neonates Feeding With SSB CoordinationIt was measured on D1, D2, D3, D5, D7 and D14number of neonates who are feeding well and showing coordinated pattern of suck swallow and breath (SSB)
• Volume Taken During the First 5 Min of Feeding (ml) VT5Volume taken during the first 5 min of feeding (ml) VT5 was measured on D1, D2, D3, D5, D7 and D14during each feed taken orally by neonate VT5 is the amount of feed was taken by neonate during first 5 minutes
•Rate of Transfer (RT) ml/MinRT was measured on D1, D2, D3, D5, D7 and D14RT is the time taken by neonate to finish oral feed
• Overall Transfer (OT Percent) Volume Taken/Total Volume PrescribedOT was measured on D1, D2, D3, D5, D7 and D14trend towards oral feed establishment and is measured as overall transfer of milk yo oral out of total amount prescribed

Countries

Pakistan

Participant flow

Recruitment details

The study period spans 16 months (March 2022 - July 2023), in the department of Neonatology, Fatima Memorial Hospital, Lahore. All preterm of gestation age 28 to 34 weeks, admitted to NICU during the study period after seeking consent from parents or guardians were enrolled. All neonates having major anomalies incompatible with life, cleft lip and palate, genetic disorders, IVH (grade III & IV), HsPDA, hemodynamic instability, NEC (stage II & III) or anemia requiring transfusion were excluded.

Pre-assignment details

Out of 142 eligible neonates, study was started with 130 as 65 in each group. Twelve neonates were excluded as 2 mothers experienced serious postnatal complications, 1 instance of parental refusal after initial participation, 1 case with incomplete data, and 8 others. Out of 65 neonates in each group, in 49 from intervention group and 48 from control group, sensory motor stimulation could be performed per protocol as 33 total neonates were excluded and details have been mentioned in table.

Participants by arm

ArmCount
Intervention Group (Group 1)
Maternal involvement was done in three stages for the intervention group as * Observer status * Performing under supervision * Independent * Study groups for sensory motor stimulation (5 minutes) + pacifier (2 minutes) Intervention group (Group I): by mothers 1. T1: Nurses performed all steps while mother observer status 2. T2: Nurses performed all steps in front of the mother and a pacifier was offered by the mother 3. D1: Mother performed all steps and oral milk was offered by the nurse while the mother observed. 4. D2: Mother performed all steps and offering oral milk under nurse supervision 5. D3: Mother performed all steps independently perioral sensory motor stimulation: Step 1 - 6 over 5 minutes <!-- --> 1. With the help of the index finger, on the external surface of the cheek, make a circle starting from the angle of the mouth towards the ear then back 7x each cheek 2. While holding both sides of the cheek with help of the thumb and index finger repeat step 1 7x each cheek 3. Move index finger from one corner to opposite one over both lips separately 7x each lip 4. Gentle massage and compress the gums from center to back of mouth 7x each half of the gum 5. Move the finger from front to back on the hard palate while applying gentle pressure 7x 6. Displace the center of the tongue with gentle pressure 7x 7. Offer pacifier at the end 2 minutes Note: 7x means 7 times
49
Control Group (Group 2)
All steps were the same as the intervention group and were performed by staff nurses perioral sensory motor stimulation: Step 1 - 6 over 5 minutes 1 With the help of the index finger, on the external surface of the cheek, make a circle starting from the angle of the mouth towards the ear then back 7x each cheek 2 While holding both sides of the cheek with help of the thumb and index finger repeat step 1 7x each cheek 3 Move index finger from one corner to opposite one over both lips separately 7x each lip 4 Gentle massage and compress the gums from center to back of mouth 7x each half of the gum 5 Move the finger from front to back on the hard palate while applying gentle pressure 7x 6 Displace the center of the tongue with gentle pressure 7x 7 Offer pacifier at the end 2 minutes Note: 7x means 7 times
48
Total97

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall Studycontinued need of mechanical ventilation23
Overall Studyfailure to establish gavage feed by 2 weeks of chronological age42
Overall StudyHsPDA requiring antifailure therapy12
Overall StudyIVH (G III & IV)21
Overall StudyNEC (stage II & III)23
Overall StudyProtocol Violation33
Overall StudyWithdrawal by Subject23

Baseline characteristics

CharacteristicControl Group (Group 2)TotalIntervention Group (Group 1)
Age, Continuous30 years29.5 years29 years
anemia of pregnancy21 Participants46 Participants25 Participants
Apnea20 Participants38 Participants18 Participants
Birth weight1.34 Kg1.31 Kg1.29 Kg
Caffeine28 Participants56 Participants28 Participants
Chronological age (ChA) at enrollment9 days11 days13 days
Discharge weight1.48 Kg1.48 Kg1.48 Kg
Duration of IMV2 days1.5 days1 days
Duration of LFNC3.5 days3.75 days4 days
Duration of non invasive ventilation (NIV)4 days3.5 days3 days
Duration of stay in NICU30 days25.5 days21 days
Feeding intolerence25 Participants45 Participants20 Participants
Gestation age at delivery31 weeks30.5 weeks30 weeks
Gestational diabetes mellitus17 Participants34 Participants17 Participants
Gravidity
2 - 3
15 Participants37 Participants22 Participants
Gravidity
4 or more
7 Participants14 Participants7 Participants
Gravidity
Primigravida (PG)
26 Participants46 Participants20 Participants
Hemodynamically significant patent ductus arteriosus (HsPDA)20 Participants37 Participants17 Participants
hypertensive disorder of pregnancy32 Participants61 Participants29 Participants
Maternal education
Higher
16 Participants37 Participants21 Participants
Maternal education
Primary
10 Participants21 Participants11 Participants
Maternal education
Secondary
20 Participants35 Participants15 Participants
Maternal education
Uneducated
2 Participants4 Participants2 Participants
Maternal Job status
home maker
31 Participants60 Participants29 Participants
Maternal Job status
job doing
17 Participants37 Participants20 Participants
Mode of delivery (SVD)29 Participants55 Participants26 Participants
mothers with previous preterm neonates38 Participants80 Participants42 Participants
Necrotizing enterocolitis (NEC)12 Participants21 Participants9 Participants
neonatal gender (male)22 Participants49 Participants27 Participants
Place of birth (Inborn)33 Participants63 Participants30 Participants
Post menstural age (PMA) at enrollment32 weeks32 weeks32 weeks
Race and Ethnicity Not Collected0 Participants
Required Invasive mechanical ventilation (IMV)30 Participants56 Participants26 Participants
Required low flow nasal cannula therapy (LFNC)43 Participants90 Participants47 Participants
Required non invasive ventilation (NIV)48 Participants93 Participants45 Participants
Respiratory distress syndrome (RDS)25 Participants50 Participants25 Participants
Seizures5 Participants12 Participants7 Participants
Sepsis41 Participants84 Participants43 Participants
Sex/Gender, Customized48 Participants97 Participants49 Participants
Time to full gavage feed7 days7 days7 days
Weight at enrollment1.35 Kg1.35 Kg1.35 Kg
Weight for gestational age
Appropriate for gestation age (AGA)
30 Participants57 Participants27 Participants
Weight for gestational age
Large for gestation age (LGA)
3 Participants9 Participants6 Participants
Weight for gestational age
Small for gestation age (SGA)
15 Participants31 Participants16 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 490 / 48
other
Total, other adverse events
16 / 4919 / 48
serious
Total, serious adverse events
0 / 490 / 48

Outcome results

Primary

•Adverse Events Monitoring

monitor for any adverse events like cough, breath holding, chocking, aspiration, tachycardia, and or bradycardia with 1. stimulation 2. feed Adverse outcome monitoring as non-life threatening adverse events including cough, tachycardia HR 180-200/min, bradycardia HR120 - 100/min, , tachypnea RR 60 - 70/min while maintaining SpO2 of \>90% at room air

Time frame: Adverse events were noted on D1, D2,D3,D5,D7 and D14

Population: All neonates were monitored for adverse outcome. This monitoring was done as non-life threatening adverse events including cough, tachycardia HR 180-200/min, bradycardia HR120 - 100/min, , tachypnea RR 60 - 70/min while maintaining SpO2 of \>90% at room air

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Intervention Group (Group 1)•Adverse Events MonitoringAdverse events D214 Participants
Intervention Group (Group 1)•Adverse Events MonitoringAverse events D50 Participants
Intervention Group (Group 1)•Adverse Events MonitoringAdverse events D312 Participants
Intervention Group (Group 1)•Adverse Events MonitoringAdverse events D7 & 140 Participants
Intervention Group (Group 1)•Adverse Events MonitoringAdverse events D131 Participants
Control Group (Group 2)•Adverse Events MonitoringAdverse events D7 & 140 Participants
Control Group (Group 2)•Adverse Events MonitoringAdverse events D136 Participants
Control Group (Group 2)•Adverse Events MonitoringAdverse events D214 Participants
Control Group (Group 2)•Adverse Events MonitoringAdverse events D312 Participants
Control Group (Group 2)•Adverse Events MonitoringAverse events D52 Participants
Primary

•Adverse Outcome Monitoring

monitor for any adverse events like cough, breath holding, chocking, aspiration, tachycardia, and or bradycardia with 1. stimulation 2. feed Adverse outcome monitoring as non-life threatening adverse events including cough, tachycardia HR 180-200/min, bradycardia HR120 - 100/min, , tachypnea RR 60 - 70/min while maintaining SpO2 of \>90% at room air

Time frame: Adverse events were noted on D1, D2,D3,D5,D7 and D14

Population: All neonates were monitored for adverse outcome. This monitoring was done as non-life threatening adverse events including cough, tachycardia HR 180-200/min, bradycardia HR120 - 100/min, , tachypnea RR 60 - 70/min while maintaining SpO2 of \>90% at room air

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Intervention Group (Group 1)•Adverse Outcome MonitoringAdverse events D214 Participants
Intervention Group (Group 1)•Adverse Outcome MonitoringAverse events D50 Participants
Intervention Group (Group 1)•Adverse Outcome MonitoringAdverse events D312 Participants
Intervention Group (Group 1)•Adverse Outcome MonitoringAdverse events D7 & 140 Participants
Intervention Group (Group 1)•Adverse Outcome MonitoringAdverse events D131 Participants
Control Group (Group 2)•Adverse Outcome MonitoringAdverse events D7 & 140 Participants
Control Group (Group 2)•Adverse Outcome MonitoringAdverse events D136 Participants
Control Group (Group 2)•Adverse Outcome MonitoringAdverse events D214 Participants
Control Group (Group 2)•Adverse Outcome MonitoringAdverse events D312 Participants
Control Group (Group 2)•Adverse Outcome MonitoringAverse events D52 Participants
Primary

Improvement (Change) in Efficiency in Oral Feed Establishment

According to this efficiency in oral feed establishment in terms of amount and time is determined for the intervention group vs the control group. It can be classified into four levels depending upon the level of maturity in ascending order as follows: * Level 1: PRO \< 30% and RT \< 1.5 ml/min * Level 2: PRO \< 30% and RT ≥ 1.5 ml/min * Level 3: PRO ≥ 30% and RT \< 1.5 ml/min * Level 4: PRO ≥ 30% and RT ≥ 1.5 ml/min For all neonates, efficacy was measured at 11.00 am and 5.00 pm following sensory motor stimulation for both groups till achievement of full oral feed.

Time frame: For record purpose in this study results, efficacy level was noted as L4 on the following days D1, D2, D3, D5, D7 and D14

Population: neonates were assessed for efficacy of level 4 (L4) on D1, D2,D3,D5,D7 and D14

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Intervention Group (Group 1)Improvement (Change) in Efficiency in Oral Feed EstablishmentL4 efficacy by D715 Participants
Intervention Group (Group 1)Improvement (Change) in Efficiency in Oral Feed EstablishmentL4 efficacy by D59 Participants
Intervention Group (Group 1)Improvement (Change) in Efficiency in Oral Feed EstablishmentL4 efficacy by D1436 Participants
Intervention Group (Group 1)Improvement (Change) in Efficiency in Oral Feed EstablishmentL4 efficacy by D1-30 Participants
Control Group (Group 2)Improvement (Change) in Efficiency in Oral Feed EstablishmentL4 efficacy by D1435 Participants
Control Group (Group 2)Improvement (Change) in Efficiency in Oral Feed EstablishmentL4 efficacy by D1-30 Participants
Control Group (Group 2)Improvement (Change) in Efficiency in Oral Feed EstablishmentL4 efficacy by D512 Participants
Control Group (Group 2)Improvement (Change) in Efficiency in Oral Feed EstablishmentL4 efficacy by D716 Participants
Primary

Transition Time to Full Oral Feeding

Time interval between commencement of perioral sensory stimulation on D1 to establishment of full oral feed in both groups. It was done daily till 14th day of perioral sensory motor stimulation. Transition time to full oral feeding was the day at which baby was able to take oral feed of volume of 120-140ml/kg/day.

Time frame: Expected time of oral feed establishment

ArmMeasureValue (MEDIAN)
Intervention Group (Group 1)Transition Time to Full Oral Feeding10 days
Control Group (Group 2)Transition Time to Full Oral Feeding9 days
Secondary

• Neonates Feeding With SSB Coordination

number of neonates who are feeding well and showing coordinated pattern of suck swallow and breath (SSB)

Time frame: It was measured on D1, D2, D3, D5, D7 and D14

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Intervention Group (Group 1)• Neonates Feeding With SSB CoordinationSSB on D123 Participants
Intervention Group (Group 1)• Neonates Feeding With SSB CoordinationSSB on D332 Participants
Intervention Group (Group 1)• Neonates Feeding With SSB CoordinationSSB on D537 Participants
Intervention Group (Group 1)• Neonates Feeding With SSB CoordinationSSB on D736 Participants
Intervention Group (Group 1)• Neonates Feeding With SSB CoordinationSSB on D1448 Participants
Intervention Group (Group 1)• Neonates Feeding With SSB CoordinationSSB on D227 Participants
Control Group (Group 2)• Neonates Feeding With SSB CoordinationSSB on D1449 Participants
Control Group (Group 2)• Neonates Feeding With SSB CoordinationSSB on D233 Participants
Control Group (Group 2)• Neonates Feeding With SSB CoordinationSSB on D739 Participants
Control Group (Group 2)• Neonates Feeding With SSB CoordinationSSB on D333 Participants
Control Group (Group 2)• Neonates Feeding With SSB CoordinationSSB on D122 Participants
Control Group (Group 2)• Neonates Feeding With SSB CoordinationSSB on D540 Participants
Secondary

• Overall Transfer (OT Percent) Volume Taken/Total Volume Prescribed

trend towards oral feed establishment and is measured as overall transfer of milk yo oral out of total amount prescribed

Time frame: OT was measured on D1, D2, D3, D5, D7 and D14

ArmMeasureGroupValue (MEDIAN)
Intervention Group (Group 1)• Overall Transfer (OT Percent) Volume Taken/Total Volume PrescribedOT on D1495.5 percentage of volume taken/total volume
Intervention Group (Group 1)• Overall Transfer (OT Percent) Volume Taken/Total Volume PrescribedOT on D235.7 percentage of volume taken/total volume
Intervention Group (Group 1)• Overall Transfer (OT Percent) Volume Taken/Total Volume PrescribedOT on D343.8 percentage of volume taken/total volume
Intervention Group (Group 1)• Overall Transfer (OT Percent) Volume Taken/Total Volume PrescribedOT on D548 percentage of volume taken/total volume
Intervention Group (Group 1)• Overall Transfer (OT Percent) Volume Taken/Total Volume PrescribedOT on D756 percentage of volume taken/total volume
Intervention Group (Group 1)• Overall Transfer (OT Percent) Volume Taken/Total Volume PrescribedOT on D121 percentage of volume taken/total volume
Control Group (Group 2)• Overall Transfer (OT Percent) Volume Taken/Total Volume PrescribedOT on D760 percentage of volume taken/total volume
Control Group (Group 2)• Overall Transfer (OT Percent) Volume Taken/Total Volume PrescribedOT on D121 percentage of volume taken/total volume
Control Group (Group 2)• Overall Transfer (OT Percent) Volume Taken/Total Volume PrescribedOT on D1491 percentage of volume taken/total volume
Control Group (Group 2)• Overall Transfer (OT Percent) Volume Taken/Total Volume PrescribedOT on D236 percentage of volume taken/total volume
Control Group (Group 2)• Overall Transfer (OT Percent) Volume Taken/Total Volume PrescribedOT on D548 percentage of volume taken/total volume
Control Group (Group 2)• Overall Transfer (OT Percent) Volume Taken/Total Volume PrescribedOT on D343.8 percentage of volume taken/total volume
Secondary

• Proficiency(PRO Percent) Volume Taken During the First 5 Min/Total Volume Prescribed

how much amount of milk is taken during first 5 minutes while administering oral feeding

Time frame: PRO % was measured on D1, D2, D3, D5, D7 and D14

ArmMeasureGroupValue (MEDIAN)
Intervention Group (Group 1)• Proficiency(PRO Percent) Volume Taken During the First 5 Min/Total Volume PrescribedPRO on D116 percentage of volume taken during the fi
Intervention Group (Group 1)• Proficiency(PRO Percent) Volume Taken During the First 5 Min/Total Volume PrescribedPRO on D221 percentage of volume taken during the fi
Intervention Group (Group 1)• Proficiency(PRO Percent) Volume Taken During the First 5 Min/Total Volume PrescribedPRO on D319.5 percentage of volume taken during the fi
Intervention Group (Group 1)• Proficiency(PRO Percent) Volume Taken During the First 5 Min/Total Volume PrescribedPRO on D529 percentage of volume taken during the fi
Intervention Group (Group 1)• Proficiency(PRO Percent) Volume Taken During the First 5 Min/Total Volume PrescribedPRO on D739 percentage of volume taken during the fi
Intervention Group (Group 1)• Proficiency(PRO Percent) Volume Taken During the First 5 Min/Total Volume PrescribedPRO on D1455.8 percentage of volume taken during the fi
Control Group (Group 2)• Proficiency(PRO Percent) Volume Taken During the First 5 Min/Total Volume PrescribedPRO on D739 percentage of volume taken during the fi
Control Group (Group 2)• Proficiency(PRO Percent) Volume Taken During the First 5 Min/Total Volume PrescribedPRO on D116 percentage of volume taken during the fi
Control Group (Group 2)• Proficiency(PRO Percent) Volume Taken During the First 5 Min/Total Volume PrescribedPRO on D530 percentage of volume taken during the fi
Control Group (Group 2)• Proficiency(PRO Percent) Volume Taken During the First 5 Min/Total Volume PrescribedPRO on D221.6 percentage of volume taken during the fi
Control Group (Group 2)• Proficiency(PRO Percent) Volume Taken During the First 5 Min/Total Volume PrescribedPRO on D1456 percentage of volume taken during the fi
Control Group (Group 2)• Proficiency(PRO Percent) Volume Taken During the First 5 Min/Total Volume PrescribedPRO on D323 percentage of volume taken during the fi
Secondary

•Rate of Transfer (RT) ml/Min

RT is the time taken by neonate to finish oral feed

Time frame: RT was measured on D1, D2, D3, D5, D7 and D14

ArmMeasureGroupValue (MEDIAN)
Intervention Group (Group 1)•Rate of Transfer (RT) ml/MinRT on D10.42 ml/min
Intervention Group (Group 1)•Rate of Transfer (RT) ml/MinRT on D30.70 ml/min
Intervention Group (Group 1)•Rate of Transfer (RT) ml/MinRT on D50.90 ml/min
Intervention Group (Group 1)•Rate of Transfer (RT) ml/MinRT on D20.71 ml/min
Intervention Group (Group 1)•Rate of Transfer (RT) ml/MinRT on D141.6 ml/min
Intervention Group (Group 1)•Rate of Transfer (RT) ml/MinRT on D71.0 ml/min
Control Group (Group 2)•Rate of Transfer (RT) ml/MinRT on D141.6 ml/min
Control Group (Group 2)•Rate of Transfer (RT) ml/MinRT on D50.83 ml/min
Control Group (Group 2)•Rate of Transfer (RT) ml/MinRT on D10.42 ml/min
Control Group (Group 2)•Rate of Transfer (RT) ml/MinRT on D20.70 ml/min
Control Group (Group 2)•Rate of Transfer (RT) ml/MinRT on D30.70 ml/min
Control Group (Group 2)•Rate of Transfer (RT) ml/MinRT on D71.0 ml/min
Secondary

• Total Volume Taken During Each Feeding

It is the measure of how much feed has been taken orally out of total feed prescribed for each feeding

Time frame: It was noted on D1, D2, D3, D5, D7 and D14

ArmMeasureGroupValue (MEDIAN)
Intervention Group (Group 1)• Total Volume Taken During Each FeedingOral feed volume/feed on D56.5 ml
Intervention Group (Group 1)• Total Volume Taken During Each FeedingOral feed volume/feed on D23 ml
Intervention Group (Group 1)• Total Volume Taken During Each FeedingOral feed volume/feed on D34 ml
Intervention Group (Group 1)• Total Volume Taken During Each FeedingOral feed volume/feed on D77.5 ml
Intervention Group (Group 1)• Total Volume Taken During Each FeedingOral feed volume/feed on D1415.5 ml
Intervention Group (Group 1)• Total Volume Taken During Each FeedingOral feed volume/feed on D12 ml
Control Group (Group 2)• Total Volume Taken During Each FeedingOral feed volume/feed on D1415.5 ml
Control Group (Group 2)• Total Volume Taken During Each FeedingOral feed volume/feed on D12 ml
Control Group (Group 2)• Total Volume Taken During Each FeedingOral feed volume/feed on D79 ml
Control Group (Group 2)• Total Volume Taken During Each FeedingOral feed volume/feed on D25 ml
Control Group (Group 2)• Total Volume Taken During Each FeedingOral feed volume/feed on D37 ml
Control Group (Group 2)• Total Volume Taken During Each FeedingOral feed volume/feed on D58 ml
Secondary

• Volume Taken During the First 5 Min of Feeding (ml) VT5

during each feed taken orally by neonate VT5 is the amount of feed was taken by neonate during first 5 minutes

Time frame: Volume taken during the first 5 min of feeding (ml) VT5 was measured on D1, D2, D3, D5, D7 and D14

ArmMeasureGroupValue (MEDIAN)
Intervention Group (Group 1)• Volume Taken During the First 5 Min of Feeding (ml) VT5VT5 on D12 ml
Intervention Group (Group 1)• Volume Taken During the First 5 Min of Feeding (ml) VT5VT5 on D23 ml
Intervention Group (Group 1)• Volume Taken During the First 5 Min of Feeding (ml) VT5VT5 on D33 ml
Intervention Group (Group 1)• Volume Taken During the First 5 Min of Feeding (ml) VT5VT5 on D55 ml
Intervention Group (Group 1)• Volume Taken During the First 5 Min of Feeding (ml) VT5VT5 on D77 ml
Intervention Group (Group 1)• Volume Taken During the First 5 Min of Feeding (ml) VT5VT5 on D1410 ml
Control Group (Group 2)• Volume Taken During the First 5 Min of Feeding (ml) VT5VT5 on D77 ml
Control Group (Group 2)• Volume Taken During the First 5 Min of Feeding (ml) VT5VT5 on D12 ml
Control Group (Group 2)• Volume Taken During the First 5 Min of Feeding (ml) VT5VT5 on D55 ml
Control Group (Group 2)• Volume Taken During the First 5 Min of Feeding (ml) VT5VT5 on D23 ml
Control Group (Group 2)• Volume Taken During the First 5 Min of Feeding (ml) VT5VT5 on D1410 ml
Control Group (Group 2)• Volume Taken During the First 5 Min of Feeding (ml) VT5VT5 on D33 ml

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026